App-Based workouts may cut insulin needs for diabetic kids
NCT ID NCT06048757
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a mobile app called Diactive-1 that guides children and teens with type 1 diabetes through resistance exercises like squats and band pulls. Over 24 weeks, researchers tracked whether the app helped lower daily insulin doses. The trial enrolled 62 participants aged 8-18 and measured changes in insulin use, blood sugar control, and fitness levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Diactive-1 mobile application delivering a resistance exercise program
- What this could lead to
- If it works, this could offer a drug-free way to help children with type 1 diabetes manage their insulin needs better.
- What could go wrong
- This is a small, early-stage trial with only 62 participants. The exercise program may be hard to stick with, and results might not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
62 people
The number who actually took part.
- Started
-
Aug 2023
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 8-18 years old * At least 6 months post-diagnosis for type 1 diabetes * Ability to complete measures and intervention program in Spanish * Access to broadband or cellular internet * Patients who signed the informed consent form prior to participation; for minors, a legal representative must provide consent and sign the informed consent form. Exclusion Criteria: * Any comorbidity limiting the capacity to participate in physical activity or inadequate understanding of the Spanish language. * Participants will be excluded if they don't have access to the internet, lack a smartphone or tablet, or are unable to use the application.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundación Miguel Servet/ Navarrabiomed
Pamplona, Navarre, 31008, Spain
-
Paediatric Endocrinology Unit at Hospital Universitario de Navarra
Pamplona, Navarre, 31008, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Can a Two-Punch immune therapy save insulin cells in newly diagnosed diabetes?
- Can a smart insulin pump tailored for pregnancy protect mothers and babies?
- Can an automated pancreas system make type 1 diabetes safer in the real world?